Search results for Neurology.
Found 40 clinical studies.
A Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Effects Of Sage-718 In Parkinson’S Disease Cognitive Impairment
- Investigator: Andrew Duker
- Posted Date: Sep 14, 2022
- Type of Study: Drug
Patterns Of Social Media Use By Autistic Communities
- Investigator: Al Lutwak
- Posted Date: Aug 30, 2022
- Type of Study: Observational/Survey
Effects Of Lingual Endurance Exercise On Rehabilitation Of Swallowing Impairment After
- Investigator: Brittany Krekeler
- Posted Date: Aug 11, 2022
- Type of Study: Device
The Influence Of Popular Media On Biases Of Potential Care Providers Toward Nonspeaking Autistic People
- Investigator: Al Lutwak
- Posted Date: Jul 25, 2022
- Type of Study: Observational/Survey
A Randomized, Placebo-Controlled, Double-Blind Study To Evaluate The Effect Of Sage-718 On Cognitive Function In Participants With Huntington’S Disease
- Investigator: Andrew Duker
- Posted Date: Jul 7, 2022
- Type of Study: Drug
Healthy Aging And Alzheimer's Disease In Epilepsy
- Investigator: Russell Sawyer
- Posted Date: Apr 25, 2022
- Type of Study: Observational/Survey
Biomarkers Of Inflammation In Large Vessel Ischemic Stroke (Blis)
- Investigator: Destiny Hooper
- Posted Date: Mar 29, 2022
- Type of Study: Observational/Survey
Evaluate The Efficacy And Safety Of Alxn2050 In Adult Participants With Generalized Myasthenia Gravis
- Investigator: Hani Kushlaf
- Posted Date: Feb 7, 2022
- Type of Study: Drug
An Exploratory Open-Label Study Of The Effects On Responsive Neurostimulator Eeg Epileptiform Activity After Intranasal Administration Of A Single Dose Of Valtoco® To People With Epilepsy With Previously Implanted Responsive Neurostimulator Systems
- Investigator: Michael Privitera
- Posted Date: Nov 8, 2021
- Type of Study: Drug
Phase 1/2, Two-Part, Open-Label Dose-Escalation And Double-Blind, Placebo-Controlled Dose-Expansion Study With An Open-Label Extension To Evaluate The Safety And Efficacy Of Ata188 In Subjects With Progressive Multiple Sclerosis
- Investigator: Aram Zabeti
- Posted Date: Jun 22, 2021
- Type of Study: Drug
Spinal Cord Injury Trial (Sponsor: Mitsubishi)
- Investigator: Justin Virojanapa
- Posted Date: Jun 14, 2021
- Type of Study: Drug
A071702 A Phase II Study Of Checkpoint Blockade Immunotherapy In Patients With Somatically Hypermutated Recurrent Glioblastoma
- Investigator: Soma Sengupta
- Posted Date: May 24, 2021
- Type of Study: Drug
Pridopidine's Outcome On Function In Huntington Disease, Proof- Hd
- Investigator: Andrew Duker
- Posted Date: Apr 30, 2021
- Type of Study: Drug
A Dose Selection Trial Of Light Therapy For Impaired Sleep In Parkinson’S Disease
- Investigator: Alberto Espay
- Posted Date: Apr 30, 2021
- Type of Study: Device
The Dystonia Coalition Natural History And Biospecimen Repository For Isolated Dystonias (Dcp)
- Investigator: Alberto Espay
- Posted Date: Apr 30, 2021
- Type of Study: Observational/Survey
Ppmi 2.0 Clinical -Establishing A Deeply Phenotyped Pd Cohort
- Investigator: Alberto Espay
- Posted Date: Apr 30, 2021
- Type of Study: Observational/Survey
Trial Of Parkinson’S And Zoledronic Acid
- Investigator: Alberto Espay
- Posted Date: Apr 30, 2021
- Type of Study: Drug
An Open-Label, Multicenter Phase 4 Study To Assess Disease Activity And Biomarkers Of Neuronal Damage In Minority Patients With Relapsing Multiple Sclerosis Receiving Treatment With Ocrelizumab
- Investigator: Lawrence Goldstick
- Posted Date: Mar 19, 2021
- Type of Study: Drug
Bn42083 A Phase IIIb Multicenter, Randomized, Double-Blind, Controlled Study To Evaluate The Efficacy, Safety And Pharmacokinetics Of A Higher Dose Of Ocrelizumab In Adults With Primary Progressive Multiple Sclerosis
- Investigator: Aram Zabeti
- Posted Date: Feb 15, 2021
- Type of Study: Drug
Effects Of Plasma Exchange On Adolescent And Adult Patients With Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (Pandas)
- Investigator: Caroline Alquist
- Posted Date: Jan 21, 2021
- Type of Study: Observational/Survey
A Phase IIIb Multicenter, Randomized, Double-Blind, Controlled Study To Evaluate The Efficacy, Safety And Pharmacokinetics Of A Higher Dose Of Ocrelizumab In Adults With Relapsing Multiple Sclerosis
- Investigator: Lawrence Goldstick
- Posted Date: Oct 29, 2020
- Type of Study: Drug
A Phase 3, Randomized, Double-Blind, Efficacy And Safety Study Comparing Sar442168 To Placebo In Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis (Hercules)
- Investigator: Lawrence Goldstick
- Posted Date: Oct 27, 2020
- Type of Study: Drug
Gn42272: A Phase III Randomized, Double-Blind Study To Evaluate Efficacy And Safety Of Fenebrutinib Compared With Teriflunomide In Patients With Relapsing Multiple Sclerosis
- Investigator: Aram Zabeti
- Posted Date: Oct 23, 2020
- Type of Study: Drug
Optimizing Training In Severe Post-Stroke Walking Impairment
- Investigator: Oluwole Awosika
- Posted Date: Sep 22, 2020
- Type of Study: Observational/Survey
Quantifying The Role Of Sensory Systems Processing In Post-Stroke Walking Recovery
- Investigator: Oluwole Awosika
- Posted Date: Sep 22, 2020
- Type of Study: Observational/Survey
Study In Parkinson's Disease Of Exercise Phase 3 Clinical Trial: Sparx3
- Investigator: Alberto Espay
- Posted Date: Sep 14, 2020
- Type of Study: Observational/Survey
Erich-Gene
- Investigator: Daniel Woo
- Posted Date: Aug 25, 2020
- Type of Study: Observational/Survey
Ehr-Embedded Decision Support To Prevent Stroke In Patients With Af
- Investigator: Mark Eckman
- Posted Date: Apr 1, 2020
- Type of Study: Observational/Survey
Cincinnati Cohort Biomarkers Program
- Investigator: Alberto Espay
- Posted Date: Mar 16, 2020
- Type of Study: Observational/Survey
Fviia For Acute Hemorrhagic Stroke Administered At Earliest Time (Fastest) Trial
- Investigator: Kyle Walsh
- Posted Date: Mar 9, 2020
- Type of Study: Drug
Neuroscience Retrospective Chart Review
- Investigator: Daniel Woo
- Posted Date: Jan 23, 2020
- Type of Study: Observational/Survey
Is Hypotension The Mechanism Behind Cognitive Fluctuations In Parkinson’S Disease Dementia And Dementia With Lewy Bodies?
- Investigator: Alberto Espay
- Posted Date: Oct 29, 2019
- Type of Study: Observational/Survey
Long-Term Extension Safety And Efficacy Study Of Sar442168 In Participants With Relapsing Multiple Sclerosis
- Investigator: Lawrence Goldstick
- Posted Date: Oct 10, 2019
- Type of Study: Drug
A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis (Ocarina)
- Investigator: Lawrence Goldstick
- Posted Date: Oct 7, 2019
- Type of Study: Drug
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Safety And Efficacy Of Ravulizumab In Complement-Inhibitor-Naïve Adult Patients With Generalized Myasthenia Gravis
- Investigator: Hani Kushlaf
- Posted Date: Sep 24, 2019
- Type of Study: Drug
Astral - Biogen Brain Contusion Study
- Investigator: Laura Ngwenya
- Posted Date: Sep 20, 2019
- Type of Study: Drug
A Study To Evaluate The Safety And Effectiveness Of A New Antiseizure Drug Called Xen1101
- Investigator: Brian Moseley
- Posted Date: Jun 12, 2019
- Type of Study: Drug
Optimizing Magnetic Resonance Imaging Acquisitions For Brain Imaging
- Investigator: Jinghua Wang
- Posted Date: Jun 6, 2019
- Type of Study: Device
Epidemiology Of Subdural Hematomas At The University Of Cincinnati Medical Center
- Investigator: David Robinson
- Posted Date: May 22, 2019
- Type of Study: Observational/Survey
An Open-Label, Single-Arm Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Patients With Early Stage Relapsing Remitting Multiple Scle
- Investigator: Lawrence Goldstick
- Posted Date: May 15, 2019
- Type of Study: Drug